Gene · 1487
Papers2,891
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,891
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gαs is dispensable for β-arrestin coupling but dictates GRK selectivity and is predominant for gene expression regulation by β2-adrenergic receptor. | J Biol Chem | 2023 | 37774973 | PubTator, text mining | PubMed |
| CRISPR/Cas9-Mediated CtBP1 Gene Editing Enhances Chemosensitivity and Inhibits Metastatic Potential in Esophageal Squamous Cell Carcinoma Cells. | Int J Mol Sci | 2023 | 37762332 | PubTator, text mining | PubMed |
| Regulation of Soluble E-Cadherin Signaling in Non-Small-Cell Lung Cancer Cells by Nicotine, BDNF, and β-Adrenergic Receptor Ligands. | Biomedicines | 2023 | 37760996 | PubTator, text mining | PubMed |
| In Silico Bioinformatics Analysis on the Role of Long Non-Coding RNAs as Drivers and Gatekeepers of Androgen-Independent Prostate Cancer Using LNCaP and PC-3 Cells. | Curr Issues Mol Biol | 2023 | 37754243 | PubTator, text mining | PubMed |
| The therapeutic potential of targeting cardiac RGS4. | Ther Adv Cardiovasc Dis | 2023 | 37724539 | PubTator, text mining | PubMed |
| Dissecting Beta-Adrenergic Receptors: The Sum of Many Parts. | JACC Basic Transl Sci | 2023 | 37719428 | PubTator, text mining | PubMed |
| Combined Targeting of NAD Biosynthesis and the NAD-dependent Transcription Factor C-terminal Binding Protein as a Promising Novel Therapy for Pancreatic Cancer. | Cancer Res Commun | 2023 | 37707363 | PubTator, text mining | PubMed |
| Fetoplacental vascular effects of maternal adrenergic antihypertensive and cardioprotective medications in pregnancy. | J Hypertens | 2023 | 37694528 | PubTator, text mining | PubMed |
| Metabolomics in Pulmonary Hypertension-A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology. | Int J Mol Sci | 2023 | 37686034 | PubTator, text mining | PubMed |
| Reduced Nitric Oxide Synthase Involvement in Aigamo Duck Basilar Arterial Relaxation. | Animals (Basel) | 2023 | 37685004 | PubTator, text mining | PubMed |
| Current Advances in Cellular Approaches for Pathophysiology and Treatment of Polycystic Ovary Syndrome. | Cells | 2023 | 37681921 | PubTator, text mining | PubMed |
| Characterization of host substrates of SARS-CoV-2 main protease. | Front Microbiol | 2023 | 37670988 | PubTator, text mining | PubMed |
| Interoceptive regulation of skeletal tissue homeostasis and repair. | Bone Res | 2023 | 37669953 | PubTator, text mining | PubMed |
| Fingerprinting heterocellular β-adrenoceptor functional expression in the brain using agonist activity profiles. | Front Mol Biosci | 2023 | 37664183 | PubTator, text mining | PubMed |
| Gastroblastoma without GLI1 and EWSR1 gene breaks. | World J Surg Oncol | 2023 | 37658451 | PubTator, text mining | PubMed |
| Vibegron shows high selectivity and potent agonist activity for β3-adrenoceptors, irrespective of receptor density. | PLoS One | 2023 | 37656760 | PubTator, text mining | PubMed |
| Src tyrosine kinase promotes cardiac remodeling induced by chronic sympathetic activation. | Biosci Rep | 2023 | 37650260 | PubTator, text mining | PubMed |
| Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma. | Leukemia | 2023 | 37648814 | PubTator, text mining | PubMed |
| H19 in Serum Extracellular Vesicles Reflects Resistance to AR Axis-targeted Therapy Among CRPC Patients. | Cancer Genomics Proteomics | 2023 | 37643783 | PubTator, text mining | PubMed |
| The DDUP protein encoded by the DNA damage-induced CTBP1-DT lncRNA confers cisplatin resistance in ovarian cancer. | Cell Death Dis | 2023 | 37633920 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1487/papers?page=10